Lightning Round: Genzyme, Goldman Sachs, U.S. Steel and More

Monday, 1 Dec 2008 | 9:32 PM ET

Genzyme : Cramer recommended averaging into Genzyme stock when the market dips like it did on Monday.

Goldman Sachs : Cramer said GS is a buy after the company reports its quarter.

Chesapeake : CHK is a sell, Cramer said. “I really think that that has gone from being one of the best to one of the worst natural gas companies.” Anadarko Petroleum is better.

Lightning Round
You say the name of a stock, and Mad Money's Jim Cramer tells you whether to buy or sell.

Emergent Biosolutions : EBS is too speculative right now, Cramer said.

Oshkosh : Cramer can’t get behind OSK right now.

U.S. Steel : Cramer’s bullish on X at these levels for the long term.

Jim's charitable trust owns Goldman Sachs.

Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the Mad Money website? madcap@cnbc.com

  Price   Change %Change


Contact Mad Money

  • Showtimes

    Monday - Friday 6p ET
  • Jim Cramer is host of CNBC's "Mad Money" and co-anchor of the 9 a.m. ET hour of CNBC's "Squawk on the Street."

Mad Money Features

  • Grab the latest CNBC gear from the NBCUniversal Store!

  • Get a behind-the-scenes look at how Cramer formulates his investment advice. "Inside the Madness" is a column, which features e-mails and more with Cramer and his researcher Nicole Urken.

  • You’ve always wanted to hit the “Hallelujah!” button. Here’s your chance.